C O M M U N I C A T I O N S
Table 3. Ring-Opening Utilizing Carbon and Nitrogen
Nucleophiles
Scheme 2. C11-C21 Fragments of Reblastatin and
Geldanamycin
a Reagents and conditions: (a) ArCHO, TfOH, DCM, -78 °C, 8a Ar′
) 63% 2,6-trans/cis ) 3:1, 8b Ar′′ ) 87% 2,6-trans/cis ) 20:1. (b) (i)
BH3‚SMe2, H2O2, THF; (ii) Me3OBF4, DCM; (iii) LiBH4, Et2O, three steps,
9a Ar′ ) 68%, dr ) 4:1, 9b Ar′′ ) 56%, dr ) 3:1. (c) Sc(OTf)3, Et3SiH,
DCM, 10a Ar′ ) 84%, 10b Ar′′ ) 63%.
a All yields are based on isolated product after purification by chroma-
tography and dr determined by 1H NMR. b Reactions were irradiated under
microwave conditions (DCM, 300 W, 70 PSI, 100 °C).
ing to note that the benzyl ether of 10b was preserved under the
described conditions.
In conclusion, an efficient method for the nucleophilic ring
opening of stereochemically well-defined aryl pyranosides is
presented. The reaction effects a formal deoxygenation of the
benzylic position to provide useful, enantioenriched, building
blocks. Future work will include further determination of the
reaction scope and application of the present methodology in natural
product synthesis.
Acknowledgment. This work was supported by NIH Grant
CA56304. J.S.P. is grateful to Dr. Fredrik Lake and Dr. Andreas
Heutling as well as Professors Jonathan Lee (Boston Univ.) and
Gwilherm Evano (Univ. of Versailles) for helpful discussions.
Figure 1. Related ansamycin antibiotics.
that both nitrogen and carbon-based nucleophiles9 participated in
the opening to give substitution on the benzylic position (entries
1-3). For example, 1a in the presence of allylsilane provided allyl
derivative 3a in 80% yield (entry 1). Utilizing trimethylsilyl azide
gave 3b in similar yields and selectivity (entry 2). Finally, TMSCN
provided 3c in lower yield but at a useful level of selectivity (entry
3). Initial experiments utilizing the described reaction conditions
gave acyclic products with moderate levels of selectivity (dr ) 1.4-
4:1) and provided the basis for the introduction of useful functional
groups at the benzylic carbon.10
Our immediate plan is to use this methodology in the synthesis
of geldanamycin 4, a potent inhibitor of heat-shock protein 90 (HSP
90). HSP 90 has been of great interest since the discovery of the
ATPase binding regions’ role in cancer and protein maintenance.11
Many inhibitors of HSP 90 are currently known, of which the
ansamycins antibiotics have received notable attention not only for
their potential role in cancer treatment but also for their synthetically
challenging molecular architecture.12
Supporting Information Available: Experimental details and
selected spectral data for all new compounds. This material is available
References
(1) (a) Kobayashi, S.; Sugiura, M.; Kitagawa, H.; Lam, W. W. L. Chem. ReV.
2002, 102, 2227. (b) Longbottom, D. Synlett 1999, 2023 and references
therein. (c) Kobayashi, S. Eur. J. Org. Chem. 1999, 15.
(2) (a) Sadow, A. D.; Tilley, T. D. J. Am. Chem. Soc. 2005, 127, 643. (b)
Rauniyar, V.; Hall, D. G. J. Am. Chem. Soc. 2004, 126, 4518. (c) Sadow,
A. D.; Tilley, T. D. J. Am. Chem. Soc. 2003, 125, 7971. (d) Newitt, L.
A.; Steel, P. G. J. Chem. Soc., Perkin Trans. 1 1997, 2033. (e) Deguin,
B.; Vogel, P.; Roulet, J. M. Tetrahedron Lett. 1997, 38, 6197.
(3) (a) Lowe, J. T.; Panek, J. S. Org. Lett. 2005, 7, 3231.(b) Lowe, J. T.;
Panek, J. S. Org. Lett. 2005, 7, 1529.(c) Su, Q; Panek, J. S. J. Am. Chem.
Soc. 2004, 126, 2425.(d) Huang, H.; Panek, J. S. J. Am. Chem. Soc. 2000,
122, 9836.
(4) (a) Nishikawa, T.; Koide, Y.; Kajii, S.; Wada, K.; Ishikawa, M.; Isobe,
M. Org. Biomol. Chem. 2005, 3, 687. (b) Umata, A.; Wakayama-shi, M.
U.S. Patent 0,060,667, 2003. (c) Baker, R. H.; Cornell, K. H.; Cron, M.
J. J. Am. Chem. Soc. 1948, 70, 1490.
In that context, we have completed the synthesis of reblastatin
5, a benzenoid ansamycin-like cell cycle inhibitor.13 Our initial route
utilized an awkward deoxygenation of the C15 carbon. Since
geldanamycin and reblastatin share several structural features, the
development of a more efficient method that addresses benzylic
(C15) deoxygenation would be useful in accessing these mole-
cules (Figure 1). We envisioned that activation of the pyran C-O
σ-bond of pyran 6, presumably through metal complexation, and
nucleophilic opening should allow for a concise synthesis of the
C11-C21 portion of the ansamycins and circumvent the need for
deoxygenation strategies.
This is showcased in the synthesis of the C11-C21 fragments
of both geldanamycin 4 and reblastatin 5 (Scheme 2). Applying
our [4+2]-annulation strategy utilizing enantioenriched (E)-crotyl-
silane 7 generated the required dihydropyran core systems 8a and
8b in excellent yield and selectivity. Selective hydroboration of
the cyclic double bond provided a secondary alcohol, which was
subsequently methylated with Meerwein’s reagent. Ester reduction
with LiBH4 provided primary alcohols 9a and 9b. Reductive
opening with Sc(OTf)3/Et3SiH gave the C11-C21 fragments of
both geldanamycin 10a14 and reblastatin 10b10 as previously
reported. In regards to functional group compatibility, it is interest-
(5) (a) Gillingham, D. G.; Kataoka, O.; Garber, S. B.; Hoveyda, A. H. J. Am.
Chem. Soc. 2004, 126, 12288. (b) Abell, A. D.; Massy-Westropp, R. A
Tetrahedron 1985, 41, 2451.
(6) (a) Gevorgyan, V.; Liu, J. X.; Rubin, M.; Benson, S.; Yamamoto, Y.
Tetrahedron Lett. 1999, 40, 8919. (b) DeNinno, M. P.; Etienne, J. B.;
Duplantier, K. C. Tetrahedron Lett. 1995, 36, 669.
(7) (a) Watanabe, S.; Sueyoshi, T.; Ichihara, M.; Uehara, C.; Iwamura, M.
Org. Lett. 2001, 3, 255. (b) For acyclic deoxygenation example using
trialkyl silanes see: Sakai, N.; Hirasawa, M.; Konakahara, T. Tetrahedron
Lett. 2005, 46, 6407.
(8) Lewis acids surveyed include SnCl4, La(OTf)3, BF3‚Et2O, Cu(OTf)2, Zn-
(OTf)3, In(OTf)3, Dy(OTf)3, and trifluoroacetic acid. None provided acyclic
materials. Triflic acid and TMSOTf provided acyclic material, albeit with
lower yields.
(9) (a) For opening of pyrans with TiCl4/allylsilanes see: Oku, A; Homoto,
Y; Harada, T. Chem. Lett. 1986, 1495. (b) For allylation of benzylic
alcohols/acetates see: Rubin, M.; Gevorgyan, V. Org. Lett. 2001, 3, 2705.
(10) Stereochemistry of the benzylic center was determined through NOE
measurements via the reduction of the azide of 3b and subsequent lactam
formation (see Supporting Information for details).
(11) (a) Jolly, C.; Morimoto, R. I. J. Natl. Cancer Inst. 2000, 92, 1564. (b)
Scheibel, T.; Buchner, J. Biochem. Pharmacol. 1998, 56, 675.
(12) (a) Cheng, H.; Cao, X.; Xian, M.; Fang, L.; Cai, T. B.; Ji, J. J.; Tunac, J.
B.; Sun, D.; Wang, P. G. J. Med. Chem. 2005, 48, 645. (b) Andrus, M.
B.; Meredith, E. L.; Hicken, E. J.; Simmons, B. L.; Glancey, R. R.; Ma,
W. J. Org. Chem. 2003, 68, 8162.
(13) Wrona, I. E.; Gabarda, A. E.; Evano, G.; Panek, J. S. J. Am. Chem. Soc.
2005, 127, 15026.
(14) Andrus, M. B.; Meredith, E. L.; Sekhar, B. B. V. S. Org. Lett. 2001, 3,
259.
JA067234O
9
J. AM. CHEM. SOC. VOL. 129, NO. 1, 2007 39